Global Health Funds - aVenture Asset Manager Research
Global Health Funds
Operating Status: Operating
Global Health Funds: A listed-company investor specializing in life science investments.
Location
New York City, NY, US
Founded
2020
Global Health Funds specializes in life science investments, focusing on companies developing innovative healthcare solutions. As a listed-company investor, they target opportunities that have the potential to improve and save lives. Their investment strategy encompasses various stages, including Series B rounds.
The firm's portfolio includes notable companies such as Biolinq, which has raised $100 million. Global Health Funds previously managed the Global Health Investment Fund, which made investments resulting in top quartile financial returns and introduced over a dozen new products to market. These products include the Jada device for postpartum hemorrhage, Euvichol vaccine for cholera, and AtomoRapid tests for HIV.
Global Health Funds - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series B1 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.